US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 7.840
  • +0.120+1.55%
Close Nov 22 16:00 ET
  • 7.840
  • 0.0000.00%
Post 16:02 ET
435.85MMarket Cap-4237P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-55.33%7.81M
23.02%6.89M
-4.88%5.05M
77.63%34.16M
37.88%5.77M
163.46%17.48M
24.70%5.6M
35.43%5.31M
1,357.77%19.23M
486.82%4.18M
Operating revenue
-55.33%7.81M
23.02%6.89M
-4.88%5.05M
77.63%34.16M
37.88%5.77M
163.46%17.48M
24.70%5.6M
35.43%5.31M
1,357.77%19.23M
486.82%4.18M
Cost of revenue
Gross profit
Operating expense
-8.39%31.66M
-17.34%31.12M
-13.93%33.24M
4.18%142.06M
-13.43%31.23M
-0.96%34.56M
11.79%37.65M
21.76%38.63M
33.62%136.37M
25.26%36.07M
Selling and administrative expenses
-16.09%6.97M
-12.81%7.33M
-10.77%7.71M
5.29%32.37M
-10.68%7.02M
4.31%8.31M
9.05%8.4M
19.75%8.64M
41.51%30.75M
24.16%7.86M
-General and administrative expense
-16.09%6.97M
-12.81%7.33M
-10.77%7.71M
5.29%32.37M
-10.68%7.02M
4.31%8.31M
9.05%8.4M
19.75%8.64M
41.51%30.75M
24.16%7.86M
Research and development costs
-5.95%24.69M
-18.64%23.8M
-14.84%25.53M
3.85%109.69M
-14.19%24.21M
-2.51%26.25M
12.60%29.25M
22.35%29.99M
31.49%105.62M
25.58%28.21M
Operating profit
-39.64%-23.85M
24.39%-24.23M
15.38%-28.19M
7.88%-107.91M
20.16%-25.46M
39.56%-17.08M
-9.81%-32.05M
-19.83%-33.32M
-16.28%-117.14M
-13.55%-31.89M
Net non-operating interest income expense
26.95%3.5M
2.76%2.87M
-8.62%2.44M
91.63%10.88M
11.95%2.66M
49.70%2.75M
128.00%2.79M
1,035.74%2.67M
407.26%5.68M
202.33%2.38M
Non-operating interest income
26.95%3.5M
2.76%2.87M
-8.62%2.44M
91.63%10.88M
11.95%2.66M
49.70%2.75M
128.00%2.79M
1,035.74%2.67M
9,518.64%5.68M
225.32%2.38M
Other net income (expense)
71.29%1.24M
-326.83%-1.62M
2.64%739K
9.73%2.83M
8.65%678K
10.75%721K
9.54%712K
9.92%720K
104.60%2.58M
624K
Special income (charges)
--0
---2.4M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--2.4M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
71.29%1.24M
9.97%783K
2.64%739K
9.73%2.83M
8.65%678K
10.75%721K
9.54%712K
9.92%720K
3.45%2.58M
--624K
Income before tax
-40.53%-19.12M
19.50%-22.98M
16.41%-25.02M
13.48%-94.2M
23.42%-22.12M
47.20%-13.61M
-4.51%-28.55M
-11.20%-29.93M
-7.46%-108.88M
0.88%-28.89M
Income tax
0
0
0
4.23M
1.99M
738K
942K
560K
0
0
Net income
-33.30%-19.12M
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
Net income continuous Operations
-33.30%-19.12M
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
Minority interest income
Net income attributable to the parent company
-33.30%-19.12M
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-33.30%-19.12M
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
Basic earnings per share
8.82%-0.31
35.71%-0.45
19.18%-0.59
10.69%-2.34
17.39%-0.57
45.16%-0.34
-6.06%-0.7
-12.31%-0.73
4.03%-2.62
10.39%-0.69
Diluted earnings per share
8.82%-0.31
35.71%-0.45
19.18%-0.59
10.69%-2.34
17.39%-0.57
45.16%-0.34
-6.06%-0.7
-12.31%-0.73
4.03%-2.62
10.39%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -55.33%7.81M23.02%6.89M-4.88%5.05M77.63%34.16M37.88%5.77M163.46%17.48M24.70%5.6M35.43%5.31M1,357.77%19.23M486.82%4.18M
Operating revenue -55.33%7.81M23.02%6.89M-4.88%5.05M77.63%34.16M37.88%5.77M163.46%17.48M24.70%5.6M35.43%5.31M1,357.77%19.23M486.82%4.18M
Cost of revenue
Gross profit
Operating expense -8.39%31.66M-17.34%31.12M-13.93%33.24M4.18%142.06M-13.43%31.23M-0.96%34.56M11.79%37.65M21.76%38.63M33.62%136.37M25.26%36.07M
Selling and administrative expenses -16.09%6.97M-12.81%7.33M-10.77%7.71M5.29%32.37M-10.68%7.02M4.31%8.31M9.05%8.4M19.75%8.64M41.51%30.75M24.16%7.86M
-General and administrative expense -16.09%6.97M-12.81%7.33M-10.77%7.71M5.29%32.37M-10.68%7.02M4.31%8.31M9.05%8.4M19.75%8.64M41.51%30.75M24.16%7.86M
Research and development costs -5.95%24.69M-18.64%23.8M-14.84%25.53M3.85%109.69M-14.19%24.21M-2.51%26.25M12.60%29.25M22.35%29.99M31.49%105.62M25.58%28.21M
Operating profit -39.64%-23.85M24.39%-24.23M15.38%-28.19M7.88%-107.91M20.16%-25.46M39.56%-17.08M-9.81%-32.05M-19.83%-33.32M-16.28%-117.14M-13.55%-31.89M
Net non-operating interest income expense 26.95%3.5M2.76%2.87M-8.62%2.44M91.63%10.88M11.95%2.66M49.70%2.75M128.00%2.79M1,035.74%2.67M407.26%5.68M202.33%2.38M
Non-operating interest income 26.95%3.5M2.76%2.87M-8.62%2.44M91.63%10.88M11.95%2.66M49.70%2.75M128.00%2.79M1,035.74%2.67M9,518.64%5.68M225.32%2.38M
Other net income (expense) 71.29%1.24M-326.83%-1.62M2.64%739K9.73%2.83M8.65%678K10.75%721K9.54%712K9.92%720K104.60%2.58M624K
Special income (charges) --0---2.4M--------------0--0------------
-Less:Impairment of capital assets --0--2.4M--------------0--0------------
Other non- operating income (expenses) 71.29%1.24M9.97%783K2.64%739K9.73%2.83M8.65%678K10.75%721K9.54%712K9.92%720K3.45%2.58M--624K
Income before tax -40.53%-19.12M19.50%-22.98M16.41%-25.02M13.48%-94.2M23.42%-22.12M47.20%-13.61M-4.51%-28.55M-11.20%-29.93M-7.46%-108.88M0.88%-28.89M
Income tax 0004.23M1.99M738K942K560K00
Net income -33.30%-19.12M22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M
Net income continuous Operations -33.30%-19.12M22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M
Minority interest income
Net income attributable to the parent company -33.30%-19.12M22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -33.30%-19.12M22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M
Basic earnings per share 8.82%-0.3135.71%-0.4519.18%-0.5910.69%-2.3417.39%-0.5745.16%-0.34-6.06%-0.7-12.31%-0.734.03%-2.6210.39%-0.69
Diluted earnings per share 8.82%-0.3135.71%-0.4519.18%-0.5910.69%-2.3417.39%-0.5745.16%-0.34-6.06%-0.7-12.31%-0.734.03%-2.6210.39%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data